Abstract
Certain groups may be at increased risk or may face particular issues when travelling. Pregnant travellers and children present several questions around vaccination, travellers’ diarrhoea, malaria and noninfectious problems that are distinctly different to other travellers. These issues are dealt with in Sects. 7.1 and 7.2. Older travellers (Sect. 7.3) are also becoming increasingly recognised as having several specific requirements that deserve their own consideration. Other groups of travellers including humanitarian workers, expatriates, VFRs and those with underlying chronic medical conditions (Sects. 7.4–7.9) all have varied requirements that are different to the standard adult traveller. Immunocompromised hosts (Sects. 7.10–7.12) present a further challenge for the travel medicine practitioner and require a significant level of expertise in order to deal with the many difficult issues that will arise within a consultation. Finally, medical tourists (Sect. 7.13) pose an entirely different set of issues that practitioners must become familiar with. This chapter provides specific information and recommendations regarding these varied groups of travellers.
Certain groups may be at increased risk or may face particular issues when travelling. This chapter provides information regarding a number of these groups.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Key Reading
The Pregnant Traveller
ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 443: air travel during pregnancy. Obstet Gynecol. 2009;114:954–5.
Antony K, Ehrenthal D, Evensen A, Iruretagoyena J. Travel during pregnancy: considerations for the obstetric provider. Obstet Gynecol Surv. 2017;72:97–115.
Carroll I, Williams D. Pre-travel vaccination and medical prophylaxis in the pregnant traveler. Travel Med Infect Dis. 2008;6:259–75.
Igbinosa I, Rabe I, Oduyebo T, Rasmussen S. Zika virus: common questions and answers. Am Fam Physician. 2017;95:507–13.
McGready R, Hamilton KA, Simpson JA, Cho T, Luxemburger C, Edwards R, Looareesuwan S, White NJ, Nosten F, Lindsay S. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg. 2001;65:285–9.
Roggelin L, Cramer J. Malaria prevention in the pregnant traveller: a review. Travel Med Infect Dis. 2014;12:229–36.
Women’s Health Committee, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. College Statement: Influenza vaccination during pregnancy (and in women planning pregnancy). 2018. https://www.ranzcog.edu.au/Statements-Guidelines. Accessed 24 Aug 2018.
Children
Australian Immunisation Handbook, Australian Government Department of Health, Canberra. 2018. https://immunisationhandbook.health.gov.au.
CDC Yellow Book. Chapter 7: International travel with infants & children. 2018. https://wwwnc.cdc.gov/travel/yellowbook/2018/international-travel-with-infants-children/traveling-safely-with-infants-children.
Fischer P, Bialek R. Prevention of malaria in children. Clin Infect Dis. 2002;34(4):493–8.
Lau C, Streeton C, David M, Sly P, Mills D. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study. J Travel Med. 2016;23:tav023.
Starr M. Paediatric travel medicine: vaccines and medications. Br J Clin Pharmacol. 2013;75(6):1422–32.
Veltri JC, Osimitz TG, Bradford DC, Page BC. Retrospective analysis of calls to poison control centers resulting from exposureto the insect repellent N,N-diethyl-M-toluamide (DEET) from 1985–1989. J Toxicol Clin Toxicol. 1994;32(1):1–16.
Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008;9(4):265–9.
Older Travellers
Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–25.
Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunol Lett. 2014;162(1 Pt B):346–53.
Burke M, Rowe T. Vaccinations in older adults. Clin Geriatr Med. 2018;34(1):131–43.
Cramer JP, Dubischar K, Eder S, Burchard GD, Jelinek T, Jilma B, et al. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: open-label, uncontrolled, multi-center, phase 4 study. Vaccine. 2016;34(38):4579–85.
Del Giudice G, Goronzy JJ, Grubeck-Loebenstein B, Lambert PH, Mrkvan T, Stoddard JJ, et al. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. NPJ Aging Mech Dis. 2018;4:1.
DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371(7):635–45.
Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289–300.
Erra EO, Kantele A. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis. Expert Rev Vaccines. 2015;14(9):1167–79.
Ewald H, Briel M, Vuichard D, Kreutle V, Zhydkov A, Gloy V. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;113(9):139–46.
Gautret P, Gaudart J, Leder K, Schwartz E, Castelli F, Lim PL, et al. Travel-associated illness in older adults (>60 y). J Travel Med. 2012;19(3):169–77.
Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428–36.
Haq K, McElhaney JE. Ageing and respiratory infections: the airway of ageing. Immunol Lett. 2014;162(1 Pt B):323–8.
Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE. Adverse event reports following yellow fever vaccination, 2007-13. J Travel Med. 2016;23(5).
Linton PJ, Thoman ML. Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart. Immunol Lett. 2014;162(1 Pt B):290–7.
Swanson KA, Schmitt HJ, Jansen KU, Anderson AS. Adult vaccination. Hum Vaccin Immunother. 2015;11(1):150–5.
Theeten H, Van Herck K, Van Der Meeren O, Crasta P, Van Damme P, Hens N. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine. 2015;33(42):5723–7.
The Older Traveller: a guide for the health professional. 1st ed. In: Baker L, Brink GK, Lipschitz S, Marcolongo T, editors. South African Society of Travel Medicine (SASTM), South African Society of Geriatrics and the International Association for Medical Assistance to Travellers (IAMAT). Dunvegan: SASTM Publications; 2016.
Van Der Meeren O, Crasta P, de Ridder M. A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix in healthy adults. Hum Vaccin Immunother. 2015;11(7):1729–34.
Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15:3.
Expatriates and Long-Term Travellers
Gamble KL, Lovell-Hawker DM. Expatriates. In: JS Keystone, P Kozarsky, D O’Freedman, HD Northdurft, BA Connor, editors. Travel medicine. Mosby Elsevier; 2008.
O’Brien DP, Biggs BA. Malaria in the expatriate and long-term traveller. Aust Prescr. 2002;25(3):66–9.
Shepherd SM, Shoff WH. Vaccination for the expatriate and long-term traveler. Expert Rev Vaccines. 2014;13(6):775–800.
Toovey S, Moerman F, Van Gompel A. Special infectious diseases risks of expatriates and long-term travelers in tropical countries. Part II: infections other than malaria. J Travel Med. 2007;14(1):50–60.
Humanitarian and Health Workers
Aid Worker Security Database. Aid worker security report 2018: figures at a glance. 2018. https://aidworkersecurity.org.
Brooks SK, Dunn R, Sage CA, Amlot R, Greenberg N, Rubin GJ. Risk and resilience factors affecting the psychological well-being of individuals deployed in humanitarian relief roles after a disaster. J Ment Health. 2015;24(6):385–413.
Gushalak BD. Humanitarian aid workers. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018. https://wwwnc.cdc.gov/travel/yellowbook/2018/advising-travelers-with-specific-needs/humanitarian-aid-workers.
Wu HM, Dhara R, Czarkowski AG, Nilles EJ. Health care workers. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018. https://wwwnc.cdc.gov/travel/yellowbook/2018/advising-travelers-with-specific-needs/health-care-workers.
Chen LH, Hamer DH. Long-term travellers and expatriates. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018. https://wwwnc.cdc.gov/travel/yellowbook/2018/advising-travelers-with-specific-needs/long-term-travelers-expatriates.
NHMRC. Vaccination for people at occupational risk. Updated 5 June 2018. In: Australian Immunisation Handbook [Available Online]. https://immunisationhandbook.health.gov.au/vaccination-for-special-risk-groups.
Travellers Visiting Friends and Relatives
Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005;19(1):49–65.
Angell SY, Cetron MS. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med. 2005;142(1):67–72.
Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291(23):2856–64.
Bui YG, Trepanier S, Milord F, Blackburn M, Provost S, Gagnon S. Cases of malaria, hepatitis A, and typhoid fever among VFRs, Quebec (Canada). J Travel Med. 2011;18:373–8.
Heywood AE, Zwar N, Forssman BL, Seale H, Stephens N, Musto J, et al. The contribution of travellers visiting friends and relatives to notified infectious diseases in Australia: state-based enhanced surveillance. Epidemiol Infect. 2016;144(16):3554–63.
LaRocque RC, Deshpande BR, Rao SR, Brunette GW, Sotir MJ, Jentes ES, et al. Pre-travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg. 2013;88:376–80.
Leder K, Tong S, Weld L, Kain KC, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43:1185–93.
Travellers with Cardiovascular Problems
Hammadah M, et al. Navigating air travel and cardiovascular concerns: is the sky the limit? Clin Cardiol. 2017;40(9):660–6.
Possick SE, Barry M. Air travel and cardiovascular disease. J Travel Med. 2004;11:243–50.
Travellers with Chronic Lung Disease
Mileno MD, Bia FJ. The compromised traveller. Infect Dis Clin North Am. 1998;12(2):369–412.
Nicholson TT, Sznajder JI. Fitness to fly in patients with lung disease. Ann Am Thorac Soc. 2014;11(10):1614–22.
Patterson JE. The pre-travel medical evaluation: the traveller with chronic illness and the geriatric traveller. Yale J Biol Med. 1992;65:317–27.
Sohail MR, Fischer PR. Health risks to air travelers. Infect Dis Clin North Am. 2005;19:67–84.
Travellers with Diabetes
Kerr D, Martinez J. (Samsun Diabetes Research Institute). Diabetes travel. www.diabetestravel.org.
Mullin R, Kruger D, Young CF, Shubrook JH. Navigating travel with diabetes. Cleve Clin J Med. 2018;85(7):537–42.
Sane T, Koivisto VA, Nikkanen P, Pelkonen R. Adjustment of insulin doses of diabetic patients during long distance flights. BMJ. 1990;301(6749):421–2.
Zwar N. Travelling with medicines in 2018. Aust Prescr. 2018;41(4):102–4.
The HIV-Infected Traveller
Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review. Travel Med Infect Dis. 2015a;13(1):31–47.
Chadwick DR, Geretti AM. Immunization of the HIV infected traveler. AIDS. 2007;21:787–94.
Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, part I. Infect Dis Ther. 2017a;6(3):303–31.
Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, part II. Infect Dis Ther. 2017b;6(3):333–61.
Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDs. 2014;28(8):397–410.
Immunization of People Living with HIV and People and people at risk of HIV infection. Clinical protocol for the WHO European region. 2017. http://www.euro.who.int/__data/assets/pdf_file/0004/78502/E90840_Chapter_12.pdf.
Ruff T, O’Brien DP. Advice to the HIV-infected traveller. In: Crowe S, Hoy J, Mills J, editors. Management of the HIV-infected patient. London: Martin Dunitz Ltd; 2002. p. 601–8.
Sidibe M, Yactayo S, Kalle A, Sall AA, Sow S, Ndoutabe M, et al. Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali. Trans R Soc Trop Med Hyg. 2012;106(7):437–44.
Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, et al. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis. 2009;48(5):659–66.
The Immunocompromised Traveller
Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review. Travel Med Infect Dis. 2015b;13(1):31–47.
Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health, Canberra; 2018. immunisationhandbook.health.gov.au. Accessed 1 Oct 2018. Section on “Vaccination of people who are immunocompromised.”
Bialy C, Horne K, Dendle C, et al. International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients. Intern Med J. 2015;45:618–23.
Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. Chapter 8: Advising travelers with specific needs—immunocompromised travelers. New York: Oxford University Press; 2017. https://wwwnc.cdc.gov/travel/page/yellowbook-home. Accessed 24 July 2018.
Hall V, Johnson D, Torresi J. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations. J Travel Med. 2018;25(1).
Kotton C, Ryan E, Fishman J. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005;5:8–14.
Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2013;56(6):861–9.
Rosdahl A, Herzog C, Frosner G, Noren T, Rombo L, Askling HH. An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression—a prospective, open-label, multi-center study. Travel Med Infect Dis. 2018;21:43–50.
Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18.
Schwartz BS, Rosen J, Han PV, et al. Immunocompromised travelers: demographic characteristics, travel destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015;93:1110–6.
Suh K, Mileno MD. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am. 2005;19:15–47.
Trofe-Clark J. Lemonovich TL and the AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):318–26.
Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23(6).
The Splenectomised Traveller
Boeddha C, de Graaf W, Overbosch D, van Genderen PJJ. Travel health preparation and travel-related morbidity of splenectomised individuals. Travel Med Infect Dis. 2012;10(4):197–200.
Crawford N, McMinn A, Nourse C, Philips L, Graham N, Jones P. Medical guidelines for individuals with asplenia or hyposplenism—paediatric guidelines (aged 0 to 18 years). Version 1, February 2016. https://spleen.org.au/VSR/information.html. Accessed 30 July 2018.
Del Portillo HA, Ferrer M, Bruggat T, et al. The role of the spleen in malaria. Cell Microbiol. 2012;14(3):343–55.
Kuchar E, Miskiewicz K, Karlikowska M. A review of guidance on immunization in persons with defective or deficient splenic function. Br J Haematol. 2015;171(5):683–94.
McCarthy AE, Mileno M. Prevention and treatment of travel-related infections in compromised hosts. Curr Opin Infect Dis. 2006;19:450–5.
Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med. 2014;371(4):349–56.
Spelman D, Buttery J, Daley A, Isaacs D, et al. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients. Intern Med J. 2008;38(5):349–56.
Spleen Australia Recommendations for the prevention of infection in asplenic or hyposplenic patients over 18 years of age. Version 33, August 2017. https://spleen.org.au/VSR/information.html. Accessed 30 July 2018.
Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366(25):2397–407.
Watson DA. Pretravel health advice for asplenic individuals. J Travel Med. 2003;10(2):117–21.
Medical Tourism
Chen LH, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis. 2013;57:1752–9.
Greenfield D, Pawsey M. Medical tourism raises questions that highlight the need for care and caution. Med J Aust. 2014;201:568–9.
Leggat P. Medical tourism. Aust Fam Physician. 2015;44(1–2):16–21.
Nelson R. Infectious risks of medical tourism. Lancet Infect Dis. 2014;14(8):680–1.
Royal Australasian College of Surgeons. Position Paper on Medical Tourism, July 2017. https://www.surgeons.org/media/16070945/2017-06-29_pos_fes-pst-026_medical_tourism.pdf.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Torresi, J. et al. (2019). Travellers with Special Needs. In: Manual of Travel Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-13-7252-0_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-7252-0_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7251-3
Online ISBN: 978-981-13-7252-0
eBook Packages: MedicineMedicine (R0)